5-amino-1mq and cd38 inhibitor synergy nad+ A systems-approach to restoration Nicotinamide N-Methyltransferase in Cardiovascular Diseases:
Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Cell Metabolism The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Inhibition of CD38 by 78c Enhanced NAD+, Alleviated Inflammation, and Decreased Oxidative Stress in Old Murine Macrophages Induced by Oral Pathogens
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





